The Chemours Company
NYSE:CCChemicals - Specialty
-$0.27 today
- Market cap
- $1.82B
- Beta
- 1.39
- P/E (TTM)
- -8.0
- EPS (TTM)
- -$2.73
- Dividend yield
- 1.61%
Volume 2.86M
Average 2.80M
CC Net Income
Bottom-line profit, the starting point for calculating cash from operations.
The Chemours CompanyNYSE: CC
Net Income · Q2 FY2026 · quarter ended Jun 2026
Net income declines year over year
Q2 FY2026 net income of $303M (cash outflow) fell 20.3% year over year, ahead of the -22.4% change in trailing-twelve-month net income. Sequentially, it rose 944.8% from the prior quarter.
Context
- Net income amounted to 6.6% of revenue in FY2025, up 5.2 pp from a year earlier.
- Net income increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 7 analysts of $123.83M (+132.1%) for the fiscal year ending Dec 2026, a step up from the -548.8% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- -$303M+944.8% QoQ
- Last fiscal yearDec 2025
- -$386M-548.8% YoY
- LTMJun 2026
- -$319M-22.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -20.3% | -32.6% | -12.3 pp |
| 1 year | -548.8% | +132.1% | +680.9 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (386M) USD
- Year-over-year change
- -548.8%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (386M) | -548.8% |
| FY2024 | 2024-12-31 | 86M | +136.1% |
| FY2023 | 2023-12-31 | (238M) | -141.2% |
| FY2022 | 2022-12-31 | 578M | -4.9% |
| FY2021 | 2021-12-31 | 608M | — |
Net Income vs competitors
How CC compares with its peers on the latest reported figures
- CC's LTM Jun 2026 net income of $319M is the 7th largest of the 19 companies compared; the peer median is $86.42M.
- Its year-over-year change of -22.4% is the 14th highest of 19, against a peer median of +11.5%.
- Net income amounts to 5.5% of revenue for CC, versus a peer median of 5.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $7.29B | +5.8% | +17.5% | 20.6% | |
| LTM Jun 2026 | $1.58B | +21.7% | +15.3% | 9.6% | |
| LTM Sep 2026 | $1.24B | +208.9% | — | 3.9% | |
| LTM Jun 2026 | $683M | -18.4% | — | 37.1% | |
| LTM Sep 2026 | $401M | -56.4% | — | 3.5% | |
| LTM Jun 2026 | $350M | -21.7% | +25.3% | 6.8% | |
| LTM Jun 2026 | $319M | -22.4% | — | 5.5% | |
| LTM Jun 2026 | $267M | +168.3% | -42.0% | 2.7% | |
| LTM Jun 2026 | $217M | -51.5% | +15.7% | 6.0% | |
| LTM Aug 2026 | $197.76M | +71.8% | -5.6% | 5.6% | |
| LTM Jun 2026 | $157.97M | +17.2% | -1.5% | 9.3% | |
| LTM Sep 2026 | $97.28M | +1184.4% | -46.7% | 4.8% | |
| LTM Mar 2026 | $89.1M | -435.0% | — | 5.0% | |
| LTM Sep 2026 | $75.56M | +269.3% | -27.1% | 5.0% | |
| LTM Jun 2026 | $72.94M | -8.3% | — | 9.6% | |
| LTM Sep 2026 | $71.8M | -70.0% | +0.6% | 2.1% | |
| LTM Mar 2026 | $61.76M | +438.4% | -55.2% | 7.5% | |
| LTM Mar 2026 | $52.34M | +708.9% | — | 47.5% | |
| LTM Jun 2026 | $1.2M | -100.1% | -38.5% | 0.0% | |
| Peer median (excluding CC) | $86.42M | +11.5% | -3.5% | 5.8% | |
Competitors are the stored peer set for CC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 608M | 578M | (238M) | 86M | (386M) |
| Depreciation & Amortization | 317M | 291M | 307M | 301M | 340M |
| Deferred Income Tax | (77M) | 20M | (158M) | (27M) | 64M |
| Stock-Based Compensation | 34M | 27M | 19M | 15M | 21M |
| Change in Working Capital | 21M | (103M) | 620M | (1.05B) | 178M |
| Accounts Receivables | (225M) | 91M | 0 | (152M) | 106M |
| Inventory | (210M) | (294M) | 58M | (146M) | (106M) |
| Accounts Payables | 281M | 105M | (72M) | (9M) | (165M) |
| Other Working Capital | 175M | (5M) | 634M | (745M) | 343M |
| Other Non-Cash Items | (89M) | (58M) | 6M | 44M | 47M |
| Operating Cash Flow | 814M | 755M | 556M | (633M) | 264M |
| Capital Expenditures | (277M) | (307M) | (370M) | (360M) | (213M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 7M |
| Purchases of Investments | (12M) | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 509M | 23M | 141M | 7M | 0 |
| Investing Cash Flow | 220M | (284M) | (229M) | (353M) | (206M) |
| Debt Repayment | (208M) | (80M) | 393M | 95M | (61M) |
| Common Stock Issued | 0 | 0 | 0 | 9M | 0 |
| Common Stock Repurchased | (173M) | (495M) | (69M) | 0 | (1M) |
| Dividends Paid | (164M) | (154M) | (149M) | (148M) | (78M) |
| Other Financing Activities | (9M) | 43M | 16M | 8M | 14M |
| Financing Cash Flow | (554M) | (686M) | 172M | (36M) | (126M) |
| Effect of Forex Changes | (34M) | (32M) | 4M | (22M) | 27M |
| Net Change in Cash | 446M | (247M) | 503M | (1.04B) | (41M) |
| Free Cash Flow | 537M | 448M | 186M | (993M) | 51M |
The Chemours Company
NYSE:CC
Intrinsic Alpha fair value
Locked
Current Price
$12.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.